Retinal detachment in eyes treated with Aurolab aqueous drainage implant for refractory glaucoma - Incidence and outcomes

Purpose:To analyze the incidence of rhegmatogenous retinal detachment (RRD) in patients who have undergone prior Aurolab aqueous drainage implant (AADI) surgery and report outcomes in terms of anatomic, visual acuity, and intraocular pressure (IOP) findings.Methods:Case records of all patients who underwent RRD repair after AADI surgery from 2013 to 2019 were retrospectively analyzed. Data collected included patient demographics, ocular examination findings at all visits including IOP and best-corrected visual acuity (BCVA) and clinical findings related to RRD both at baseline and postoperatively.Results:Ten eyes of nine patients were included in study. The mean age of patients was 28.2 years (median: 15 years, range: 6–83 years). Mean duration between AADI and RRD was 14 months (median 2.5 months; range 2 days-72 months). All eyes underwent pars plana vitrectomy with silicon oil injection. The preoperative LogMAR BCVA (logarithm of the minimum angle of resolution) was 2.52 ± 0.15 which improved to 2.29 ± 0.58 at final follow-up; however, only one eye had vision ≥ 20/400 largely due to recurrent RRD and advanced glaucomatous disc damage. Postoperatively retina was attached in 6 eyes (60%) and IOP was ≤ 21 mmHg in 5 out of 6 eyes with anatomic successConclusion:The incidence of RRD following AADI was found to be 0.86% in our study. Pars plana vitrectomy (PPV) with silicon oil tamponade was the preferred approach in the management of these eyes with IOP being well controlled post PPV. However, visual acuity outcomes were largely unsatisfactory due to recurrent RRD and preexisting advanced glaucoma.     

硅油眼复发性视网膜脱离的特点及临床处理

目的 探讨硅油眼复发性视网膜脱离的特点及手术方法的选择.方法 回顾性分析本院2012年1月至2015年12月硅油填充术眼复发视网膜脱离者134例(134眼),采用玻璃体切割联合硅油置换术或巩膜外加压术治疗,术后随访6个月,评价手术效果.结果 101眼采用玻璃体切割联合硅油置换治疗,术后79眼视网膜复位,22眼视网膜复位失败者再次行玻璃体切割手术,成功率为78.2％ (79/101);视力提高者16眼,不变者56眼,下降者29眼;眼压升高超过25 mmHg(1 kPa=7.5mmHg)者31眼.33眼采用巩膜外加压治疗,23眼视网膜复位,10眼术后随访中发现视网膜未复位而改行玻璃体切割联合硅油置换术,成功率为69.7％ (23/33);视力提高者5眼,不变者16眼,下降者12眼;眼压升高超过25 mmHg者14眼.结论 对于下方或较周边的裂孔导致的局限性视网膜脱离,增生性玻璃体视网膜病变处于A或B级,屈光介质不影响眼底检查的病例,可选巩膜外加压术;对于裂孔位于后极部或较大裂孔导致的大范围视网膜脱离,并有较广泛的视网膜增殖或视网膜固定皱襞形成,建议选玻璃体联合硅油置换手术,松解牵拉,填充硅油.     

25G玻璃体切除术联合空气填充治疗原发性孔源性视网膜脱离的短期疗效

目的 观察25G玻璃体切除术联合眼内无菌空气填充治疗原发性孔源性视网膜脱离的疗效。设计 回顾性病例系列。研究对象 2016年8-12月北京同仁医院接受25G经睫状体平坦部三通道微创玻璃体切除术联合无菌空气填充治疗的原发性孔源性视网膜脱离患者13例（13眼）。上方单一裂孔8例,多发裂孔4例,黄斑裂孔1例。方法 术前均行矫正视力、眼压、裂隙灯检查、间接检眼镜、彩色眼底照相、眼部彩色多普勒超声和相干光断层扫描检查。术后平均随访（67±26）天。主要指标 矫正视力、眼压、视网膜复位及手术并发症情况。 结果 末次随访时13眼（100%）视网膜脱离全部复位。3例在术后第3天发生脉络膜脱离,口服糖皮质激素治疗后好转。术后平均logMAR矫正视力（0.63±0.43）,与术前比较差异有统计学意义（配对秩和检验S=-34, P=0.005）。末次随访平均眼压（15.95±4.12）mmHg,与术前比较差异有统计学意义（t=-2.65,P=0.02）。 结论 空气短期填充可作为25G玻璃体切除术治疗脱离位于上方、未超过3个象限的原发性孔源性视网膜脱离的一种选择方法。（眼科,2018, 27： 377-380）     

脉络膜脱离型视网膜脱离术前玻璃体腔注射曲安奈德的临床疗效

目的:探讨术前玻璃体腔注射曲安奈德对微创玻璃体切割术治疗脉络膜脱离型视网膜脱离的临床疗效.方法:选择我院2015-01/2016-06临床确诊的脉络膜脱离型视网膜脱离患者23例23眼,入院后先行玻璃体腔内注射曲安奈德4~5 d后行23 G玻璃体切割和硅油填充术.观察手术前后视力、眼压情况,以及术后视网膜复位率和并发症情况.随诊6~9 mo.结果:曲安奈德注射后前房反应均减轻,眼压升高,由入院眼压4.02±1.47mmHg升高到术前13.69±4.68mmHg,术后升高到17.72±5.88mmHg,入院时眼压与术前和术后比较,差异均有统计学意义(P<0.05).患者术后末次随访视力较术前均有所改善,视力术后≥0.3者9眼(39%),术后≥0.05者18眼(78%).术后1wk,1、3mo和末次随访矫正视力与术前比较,差异均有统计学意义(P<0.05).视网膜复位情况:手术后2 wk有23眼(100%)全视网膜在位,一次视网膜解剖复位率87%,二次视网膜解剖复位率100%.术后1 mo时3眼出现下方视网膜局限性脱离,经二次手术巩膜外垫压后视网膜复位.无眼内出血、医源性视网膜裂孔、眼内感染、晶状体损伤等并发症.术后一过性高眼压7眼,均出现在术后12~14d,减少局部激素滴眼液使用和点用降眼压滴眼液后,眼压控制在正常范围.结论:术前玻璃体腔注射曲安奈德进行预手术处理,能够提高微创玻璃体切割术治疗脉络膜脱离型视网膜脱离的疗效,降低手术难度,提高视力,避免了全身使用激素的副作用.     

25G玻璃体切割术后空气与硅油填充治疗孔源性视网膜脱离的疗效比较

目的:比较25G玻璃体切割术(PPV)联合空气或硅油填充治疗孔源性视网膜脱离(RRD)的疗效。方法:前瞻性随机对照研究。收集2018-01/12经我院确诊的RRD患者146例146眼,根据25G PPV术后眼内填充物分为空气组(60例60眼)和硅油组(86例86眼)。术后随访6~12mo,分析两组患者最佳矫正视力(BCVA)、眼压、视网膜解剖复位率及并发症情况。结果:术后1mo,空气组患者BCVA为0.45±0.5,硅油组为0.78±0.65,两组患者BCVA均较术前明显改善,且空气组患者BCVA明显优于硅油组(均P<0.05)。术后3mo,空气组患者视网膜解剖复位率(93.3%)低于硅油组(97.7%),但无差异;术后6mo,两组患者视网膜解剖复位率均为100.0%。本研究纳入患者术中主要并发症是医源性裂孔(6.8%),术后主要并发症是高眼压,术后早期(7d内)硅油眼高眼压比例明显高于空气组(P<0.001),但随访期间两组患者均未出现感染性眼内炎、脉络膜出血等严重并发症。结论:对于简单新鲜的RRD患者,25G PPV术后空气和硅油填充视网膜解剖复位率无差别,术后早期空气填充眼视力优于硅油填充眼,术后高眼压发生率更低。     

视网膜脱离晶状体切除术中保留前囊膜的临床观察

目的观察视网膜脱离晶状体切除术中保留前囊膜的疗效。方法视网膜脱离34例(34眼)患者行视网膜脱离晶状体切除术,术中切除晶状体及玻璃体,保留前囊膜,同时行硅油填充。术后随访6～24个月,平均18.5个月,观察患者随访末期视网膜复位、视力及并发症情况。结果术后视网膜裂孔封闭、视网膜复位21例,复位率61.8%。术后视力高于术前,差异有统计学意义(P<0.05)。术后并发症有角膜水肿伴硅油继发性青光眼、前房纤维素性渗出、玻璃体再次积血、黄斑区及周围视网膜点状出血、渗出等。结论视网膜脱离晶状体切除术中保留前囊膜可减少并发症的发生,有利于视力提高。     

Anatomical and functional outcomes after Densiron 68 heavy silicone oil tamponade for complicated retinal detachment in Chinese eyes

AIM:To evaluate the safety and efficacy of Densiron 68 heavy silicone oil (HSO) tamponade for complicated retinal detachment (RD) in Chinese eyes.METHODS: Twenty-one eyes of 21 patients with complicated RD were included in this retrospective study. All patients underwent pars plana vitrectomy with an internal tamponade using Densiron 68 HSO. Anatomical and functional results and complications were evaluated, including retinal status, visual acuity (VA), intraocular pressure (IOP), intraocular inflammation, lens opacity, and HSO emulsification.RESULTS:All the patients were followed up for 3mo to 1y (5.8±1.16mo). Retinal reattachment was achieved in 19 of 21 patients (90.5%). VA improved in 18 of 21 patients (85.7%), from 1.93 logMAR (±0.48) to 1.52 logMAR (±0.45) (P=0.001). Postoperative complications included early dispersion of HSO in 7 eyes (38.8%), cataract in 10 of 18 phakic eyes (55.5%), moderate postoperative inflammation reaction in 10 eyes (47.6%), and elevated IOP in 5 eyes (23.8%), all of which were controlled by medication or by surgery.CONCLUSION: High anatomical and functional success rates can be achieved with primary vitrectomy for complicated RD by using Densiron 68 HSO; however, it should not be ignored that Densiron 68 HSO can cause some complications in the eye.     

Safety and efficacy of suprachoroidal triamcinolone acetonide for the management of serous choroidal detachment prior to rhegmatogenous retinal detachment surgery: A Pilot study

Purpose:To study the safety and efficacy of pre-operative suprachoroidal triamcinolone acetonide (SCTA) for achieving reduction/resolution of serous choroidal detachment (CD) associated with rhegmatogenous retinal detachment (RRD).Methods:This was a prospective, noncomparative, interventional pilot study. All consecutive patients presenting with RD and coexisting CD underwent transconjunctival injection of SCTA before proceeding with vitrectomy/scleral buckle surgery. Sequential ultrasound B scans were performed for assessing the change in height of the CD.Results:The mean age of the cohort was 53.8 ± 10.8 years (range: 39–72 years). The CD was present in a median of 3 quadrants; the cumulative mean CD height was 5.59 mm (range: 2.02–9.42 mm). Following SCTA, a successful response (>50% reduction) was seen in five eyes by day 3 and in two eyes by day 5. Three eyes failed to respond to SCTA and required surgical drainage before proceeding with vitrectomy. No intraprocedural injection-related complications were noted. A transient rise in the intraocular pressure (30 mmHg) was seen in one eye following vitrectomy and was managed successfully with topical antiglaucoma medicationsConclusion:Suprachoroidal administration of triamcinolone appears to be a safe and effective technique to achieve CD resolution in eyes with RRD.     

玻璃体切除术联合巩膜外环扎治疗脉络膜脱离型视网膜脱离

目的：探讨玻璃体切除联术合巩膜外环扎治疗脉络膜脱离型视网膜脱离的临床疗效。

方法：回顾性分析2014-01/2018-02在我院行玻璃体切除术联合巩膜外环扎治疗的脉络膜脱离型视网膜脱离患者19例19眼,术后3～12mo行玻璃体腔硅油取出术。观察患者术后视网膜复位率、眼压、视力恢复及并发症情况。

结果：本组患者术后视网膜均复位,术后3mo患眼玻璃体腔硅油填充状态下眼压(16.09±3.58mmHg)、硅油取出术后6mo眼压(14.69±3.10mmHg)均高于术前(6.78±1.90mmHg)(均P<0.05)。硅油取出术后6mo,15眼患者视力较术前提高。术后无低眼压及眼球萎缩等并发症发生。

结论：玻璃体切除术联合巩膜外环扎治疗脉络膜脱离型视网膜脱离是相对安全有效的,视网膜复位率高,术后并发症少,再次手术率低。     

Macular hole as a risk factor of choroidal detachment in rhegmatogenous retinal detachment

PURPOSE: Choroidal detachment (CD) associated with rhegmatogenous retinal detachment (RRD) is a rare, but serious condition, which makes the prognosis worse. Previously reported risk factors for CD in RRD patients include high myopia, aphakia, pseudophakia, and advanced age. However, macular hole has not been discussed as an important factor in increasing the risk of CD in RRD patients. The purpose of this study was to evaluate macular hole as a risk factor for CD in eyes evidencing RRD. METHODS: The medical records of 480 patients with primary RRD were reviewed. We compared the CD incidence among the RRD patients in accordance with the presence or absence of macular holes. The relationship between gender, age, presence of systemic disease, refractive errors, lens status, intraocular pressure and the development of CD were also analyzed. RESULTS: The incidence (4/21 eyes, 19.0%) of CD in the RRD with macular hole was significantly higher than that (7/459 eyes, 1.5%) observed in the RRD without macular hole (p=0.010). The preoperative intraocular pressure (mean+/-SD; 2.5+/-1.3 mmHg) in the RRD with CD and macular hole was significantly lower than that (7.4+/-4.4 mmHg) observed in the cases of RRD with CD without macular hole (p=0.035). The eyes complicated by CD evidenced a higher prevalence of diabetes mellitus (p=0.024) than was observed in the eyes without CD. CONCLUSIONS: The retinal detachment combined with macular hole creates a predisposition toward the development of profound hypotony and CD.     

视网膜脱离患者玻璃体切除硅油填充术后3天高眼压发生率及危险因素

目的 探讨玻璃体切除及硅油填充术治疗视网膜脱离术后3天内眼压升高的发生比例及危险因素。设计 前瞻性病例系列。研究对象 2018年2-8月北京大学第三医院连续行玻璃体切除术联合硅油填充术治疗的视网膜脱离患者135例。方法  使用回弹式眼压计测量患者术后2、4、6~8小时、1、2、3天的眼压。任何时间眼压≥25 mmHg定义为眼压升高。生存期定义为从玻璃体切除术结束至第一次眼压≥25 mmHg发生时的时间间隔（小时）。采用Cox回归分析评估术后3天内发生高眼压的相关危险因素。采用Kaplan-Meier生存曲线可视化不同病因的视网膜脱离患者的生存概率。主要指标 高眼压发生率及危险因素。结果 135例患者中44例（32.6%）发生眼压升高,眼压升高在术后第1天发生率最高（20.2%）。Cox分析显示视网膜脱离的病因与眼压升高显著相关（P=0.006）,以原发性孔源性视网膜脱离作为对照,糖尿病性牵引性视网膜脱离和复发性视网膜脱离发生眼压升高的风险分别为3.5 倍（P=0.002,HR=3.41） 和3倍 （P=0.010,HR=2.91）。糖尿病牵引性视网膜脱离和复发性视网膜脱离的总生存率显著低于原发性视网膜脱离和外伤性视网膜脱离（P<0.05）。结论 视网膜脱离患者行玻璃体切除硅油填充术后3天内眼压升高比例约占1/3,主要发生在术后第1天。对于玻璃体切除硅油填充眼特别是糖尿病牵引性视网膜脱离及复发性视网膜脱离者,术后第1天复查仍有必要性。（眼科,2022,31：27-32）     

ILMP及玻璃体腔注药联合硅油填充治疗高度近视MHRD合并脉络膜脱离

目的:观察内界膜剥除(internal limiting membrane peeling,ILMP)和玻璃体腔注射曲安奈德联合硅油填充治疗高度近视黄斑裂孔性视网膜脱离合并脉络膜脱离的临床疗效.方法:高度近视黄斑裂孔性视网膜脱离合并脉络膜脱离患者28例28眼,均行玻璃体切割(pars plana vitrectomy,PPV)吲哚菁绿辅助的ILMP以及硅油填充手术,术中将曲安奈德注射于玻璃体腔,术后随访6~24mo,观察术后视网膜复位率、视力恢复情况和术后并发症.结果:术后随访6~24mo,患者手术后平均LogMAR矫正视力为1.01± 0.31,与手术前平均LogMAR矫正视力比较,差异有统计学意义(t=-39.28,P<0.01).黄斑裂孔闭合19眼(68%),黄斑裂孔未闭合9眼(32%),26眼视网膜复位(93%),6眼出现高眼压.结论:玻璃体切割联合ILMP及硅油填充和玻璃体腔注射曲安奈德治疗高度近视黄斑裂孔性视网膜脱离合并脉络膜脱离,可阻止增生性玻璃体视网膜病变的再生,提高视网膜复位率.     

Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment

AIM: To report the effectiveness and safety of primary 23-Gauge (G) vitreoretinal surgery for rhegmatogenous retinal detachment (RRD). METHODS: In this retrospective study, 49 eyes of 49 consecutive patients who underwent primary 23-G transconjunctival sutureless vitrectomy (TSV) for RRD between January 2007 and July 2009 at our institution were evaluated. RESULTS: Mean follow-up time was 8.9±7.7 months (1-28 months). Retinal reattachment was achieved with a single operation in 47(95.9%) of 49 eyes. In two eyes (4.1%), retinal redetachment due to new breaks was successfully treated with reoperation using the 23-G TSV system. Mean logMAR visual acuity was 2.01±0.47 preoperatively and 1.3±0.5 postoperatively (P<0.001, Paired t-test). Mean preoperative intraocular pressure (IOP) was 14.1±2.8mmHg. Mean postoperative IOP was 12.3±3.6mmHg at 1 day, 13.1±2.1mmHg at 1 week, 14.3±2.2mmHg at 1 month. Iatrogenic peripheral retinal break was observed in 1 eye (2.0%) intraoperatively. No sutures were required to close the scleral or conjunctival openings, and no eyes required convertion of surgery to 20-G vitrectomy. CONCLUSION: Primary 23-G TSV system was observed to be effective and safe in the treatment of RRD.     

硅油填充术后早期高眼压的临床分析

目的：探讨玻璃体切割硅油填充术后早期高眼压的原因、临床表现及术后处理。 方法：对行玻璃体切割硅油填充术后的97例97眼患者的临床资料进行回顾性分析,高眼压的标准为术后眼压≥21mmHg（1mmHg=0.133kPa）。 结果：患者27例（27.84%）出现高眼压,以术后早期（术后1wk内）为多,所有患者经降眼压药物治疗及调整激素用量或停用激素处理后,眼压均控制在正常范围（10～21mmHg）。 结论：硅油填充术后早期高眼压是常见的并发症之一,术后眼内组织水肿、炎症反应、硅油填充过量等可能是引起术后早期高眼压的主要原因,但早期对症治疗均使眼压恢复正常,可早期预防视功能的损害。     

玻璃体切除术治疗合并脉络膜脱离的孔源性视网膜脱离

目的探讨玻璃体切除术治疗合并脉络膜脱离的孔源性视网膜脱离的临床疗效。方法对连续治疗的12例(12只眼)合并有脉络膜脱离的孔源性视网膜脱离眼,进行玻璃体切除联合长效气体或硅油填充治疗,所有患者术前、术后均用激素治疗,对视网膜的复位率进行评价。结果术后平均随访10.42个月。单次手术视网膜解剖复位率为91.67%(11/12),再次手术后视网膜解剖复位率为100%。结论玻璃体切除术是治疗合并脉络膜脱离的孔源性视网膜脱离的有效方法。     

25G玻璃体切除联合空气填充术治疗孔源性视网膜脱离

目的:观察玻璃体切除联合空气填充术治疗孔源性视网膜脱离的临床疗效,评价空气填充的有效性及安全性。方法:对2017-08/2018-12就诊于遵义市第一人民医院的孔源性视网膜脱离并接受玻璃体切除联合空气填充术的患者30例30眼进行回顾性分析,观察术眼术前、术后1 wk,1 mo最佳矫正视力(BCVA,LogMAR)、眼压、术后视网膜复位情况及术后并发症情况等。结果:术前,术后1wk,1mo BCVA分别为0.87±0.71、0.64±0.36、0.37±0.22,手术前后术眼BCVA有差异(F=3.74,P=0.047)。术前,术后1wk,末次随访眼压分别为13.61±3.57、15.74±4.84、14.05±2.88mmHg,手术前后眼压无差异(F=4.13,P=0.051)。术后1wk视网膜复位率97%(29/30)。术后OCT监测1眼出现持续视网膜下积液,术后3mo积液吸收。结论:玻璃体切除联合空气填充术治疗孔源性视网膜脱离疗效确切,术后恢复快,提高视觉质量,同时减少患者经济负担。     

硅油取出术后视网膜再脱离的危险因素分析

目的：探讨硅油取出术后视网膜脱离复发的危险因素。

方法：我们对2008-01/2011-10所有在本中心眼底病小组行硅油取出的125例128眼患者进行回顾分析性研究,所有眼在之前均由于各种原因导致视网膜脱离而在我中心行玻璃体切除加硅油填充术。我们采用二元逻辑性回归对硅油取出术后视网膜再脱离的可能相关危险因素进行分析,包括性别、年龄、原发病的诊断、硅油取出术前的晶状体状态、硅油在眼内存留时间、硅油取出术前所进行的眼后节手术操作次数、是否做过巩膜外环扎、玻璃体切割的手术方式(20G或23G)、行硅油取出术时是否同时进行眼前段或视网膜的手术操作。

结果：在所有行硅油取出术的128眼中有23眼(18.0%)发生复发性视网膜脱离,硅油取出术前眼后节手术的次数和原发病的诊断类型是视网膜脱离复发的独立相关危险因素。硅油在眼内的存留时间与硅油取出术前眼压升高(IOP≥25mmHg)存在正相关。

结论：硅油取出术后存在较高的视网膜脱离复发的风险,尤其是严重的眼外伤导致的视网膜脱离以及之前反复手术的患者。     

Rhegmatogenous retinal detachment associated with massive spontaneous suprachoroidal hemorrhage and prognosis of pars plana vitrectomy

AIM:To describe the clinical characters of rhegmatogenous retinal detachment (RRD) associated with massive spontaneous suprachoroidal hemorrhage (SSCH). To evaluate optimal timing and prognosis of pars plana vitrectomy.METHODS: A retrospective review of 6 cases (6 eyes) of RRD and massive SSCH among 3772 cases of RRD was conducted. All of 6 patients were treated with twenty-gauge vitrectomy, suprachoroidal blood drainage, phacoemulsification (PHACO) or lensectomy and silicon oil tamponade. The clinical characters, intraoperative findings and treatment outcomes were reported.RESULTS: In the 6 affected eyes of 6 patients (3 men and 3 women; mean age, 53.83y; range 34-61y), preoperative visual acuity ranged from faint light perception (LP) to counting finger (CF). The average interventional duration from visual decreased to surgery was 12.8 d (range 9-15d). All eyes were associated with high myopia and the mean ocular length was 30.32 mm (range 28.14-32.32 mm). Choroidal hemorrhage were successfully drained in the operation of all 6 eyes. Intraoperative findings showed there were multiple retinal breaks in all 6 eyes and in 4 eyes breaks were along supratemporal and/or infratemporal retinal vascular arcade, especially in the edge of chorioretinal atrophy areas. These patients were followed up from 6 to 34mo (Mean, 23.5mo). The best-corrected visual acuity after surgery varied from CF to 20/100, with improvement in 5 eyes (83.33%) and no change in 1 eye (16.67%). Ocular hypertension ocurred in 1 eye (16.67%), which was successfully treated by silicon oil removal combined with trabeculectomy. In 4 eyes, tractional retinal detachment caused by proliferative vitreoretinopathy (PVR) appeared and a secondary surgery of pre-retinal membrane peeling and silicon oil retained were performed. In 4 eyes, silicon oil cannot be removed. The initial and final reattachment rates were 33.33% and 66.67%, respectively.CONCLUSION: RRD associated with massive SSCH is an extremely rare event. The most common risk factor is long axial length. Vitrectomy and choroidal blood drainage can effectively remove suprachoroidal hemorrhage and promote retinal reattachment in these eyes. However, silicon oil could not be removed in most eyes and final visual acuities are generally poor.     

硅油填充治疗外伤感染性眼内炎伴视网膜脱离

目的 探讨硅油填充治疗外伤性感染性眼内炎伴视网膜脱离的效果和影响因素。方法 回顾性分析1995年1月至2002年12月，我院眼科行硅油填充治疗外伤性感染性眼内炎伴视网膜脱离的16例16眼临床资料。结果 感染性眼内炎均得到控制。视网膜完全复位11眼(68．8％)，限局性视网膜脱离3眼(18．8％)，完全脱离2眼(12．5％)。术后视力光感-0．04者11眼，≥0．05者5眼。结论 应用硅油填充术能够有效地治疗外伤性感染性眼内炎伴视网膜脱离，术后并发症主要是视网膜脱离复发和增生性玻璃体视网膜病变(PVR)。     

23G玻璃体视网膜手术治疗孔源性视网膜脱离

目的：报告23G玻璃体视网膜手术治疗孔源性视网膜脱离（rhegmatogenous retinal detachment,RRD）的有效性和安全性。 方法：本回顾性研究中,49例49眼RRD患者于2007-01/2009-07在我院行23G经巩膜无缝线玻璃体切除术纳入研究。 结果：平均随访时间8.9±7.7mo(1~28mo)。47眼(95.9%)视网膜再次脱离经一次手术治愈,2眼因新出现裂孔的视网膜再次脱离通过23G经巩膜无缝线玻璃体切除术治愈。术前平均logMAR视力2.01±0.47,术后1.3±0.5(P<0.001, Paired t-test)。术前平均眼压（intraocular pressure,IOP）14.1±2.8mmHg,术后1d平均眼压12.3±3.6mmHg,术后1wk平均眼压13.1±2.1mmHg,术后1mo平均眼压14.3±2.2mmHg。术中医源性周边视网膜裂孔1眼(2.0%)。巩膜或结膜切口不要求缝合,无1眼需要转换为20G玻璃体切除术。 结论：23G经巩膜无缝线玻璃体切除术可以有效,安全的治疗RRD。